Table 1.
Correlation between JARID1B expression and clinicopathological parameter in NSCLC patients
| Parameters | JARID1B-low expression (n = 19) | JARID1B-high expression (n = 53) | χ2 value | p value |
|---|---|---|---|---|
| Age (years) | ||||
| ≦ 50 | 8 (42.1%) | 20 (37.7%) | 0.112 | 0.737 |
| > 50 | 11 (57.9%) | 33 (62.3%) | ||
| Tumor size | ||||
| ≦ 2 cm | 12 (63.2%) | 15 (28.3%) | 7.250 | *0.007 |
| > 2 cm | 7 (36.8%) | 38 (71.7%) | ||
| Differentiation | ||||
| Poor | 6 (31.6%) | 23 (43.4%) | 0.828 | 0.382 |
| Moderate | 12 (63.2%) | 28 (52.8%) | ||
| Well | 1 (5.2%) | 2 (3.8%) | ||
| LN metastasis | ||||
| Negative | 16 (84.2%) | 25 (47.2%) | 7.827 | *0.005 |
| Positive | 3 (15.8%) | 28 (52.8%) | ||
| Stage | ||||
| I, II | 14 (73.7%) | 24 (45.3%) | 4.527 | *0.033 |
| III | 5 (26.3%) | 29 (54.7%) | ||
*Statistically significant values